Stay updated with breaking news from Brian Culley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the results of imaging analyses...
Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to generate a novel hypoimmune induced pluripotent stem cell (iPSC) line under the company’s exclusive option and license agreement with Eterna Therapeutics Inc (NASDAQ:
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q2 2023 Earnings Call Transcript August 10, 2023 Lineage Cell Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.04. Operator: Welcome to the Lineage Cell Therapeutics Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. An audio webcast of this call […]
Patients enrolled were diagnosed with refractory, metastatic or locally advanced, non-small cell lung cancer , for whom there were no other suitable treatment options Five of eight patients...
Operator: Welcome to the Lineage Cell Therapeutics First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.